Relmada Therapeutics, Inc.

NasdaqGS:RLMD Stock Report

Market Cap: US$76.9m

Relmada Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:RLMD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Jan 24BuyUS$150,920Charles EnceIndividual38,970US$4.05
31 Jan 24BuyUS$125,717Maged ShenoudaIndividual32,675US$4.06
31 Jan 24BuyUS$386,738Sergio TraversaIndividual100,000US$4.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RLMD?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,415,2438%
Institutions13,642,24945.2%
General Public14,116,71046.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 45.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.3%
Kevin Kotler
1,899,930US$4.8m0%no data
4.16%
The Vanguard Group, Inc.
1,256,705US$3.2m0%no data
4.09%
Deep Track Capital, LP
1,234,773US$3.1m-0.42%0.09%
3.98%
Vestal Point Capital, LP
1,200,000US$3.1m0%0.22%
3.95%
Acadian Asset Management LLC
1,193,333US$3.0m1.03%0.01%
3.36%
Franklin Resources, Inc.
1,012,661US$2.6m60.7%no data
3.23%
Parsons Capital Management, Inc.
975,945US$2.5m0.25%0.18%
2.43%
Palo Alto Investors LP
732,400US$1.9m0%0.23%
1.99%
Opaleye Management Inc.
600,000US$1.5m-21%0.3%
1.9%
BlackRock, Inc.
573,314US$1.5m-0.84%no data
1.17%
JPMorgan Chase & Co, Brokerage and Securities Investments
352,616US$899.2k100%no data
0.97%
Two Sigma Advisers, LP
292,500US$745.9k-10.3%no data
0.86%
Geode Capital Management, LLC
260,498US$664.3k1.72%no data
0.81%
Sergio Traversa
244,024US$622.3k0%no data
0.79%
Tang Capital Management, LLC
237,874US$606.6k62,200%0.06%
0.75%
Deutsche Asset & Wealth Management
224,846US$573.4k0%no data
0.69%
Bank of America Corporation, Asset Management Arm
206,719US$527.1k-1.83%no data
0.67%
Two Sigma Investments, LP
203,261US$518.3k-10.5%no data
0.62%
Paul Kelly
187,295US$477.6k0%no data
0.6%
Bridgeway Capital Management, LLC
181,077US$461.7k-7.51%0.01%
0.55%
RBF Capital LLC
165,474US$422.0k0%0.03%
0.52%
Marshall Wace LLP
156,619US$399.4k-24.7%no data
0.49%
Group One Trading LP, Asset Management Arm
148,927US$379.8k-19.2%0.01%
0.48%
Barclays PLC Private Banking & Investment Banking Investment
145,999US$372.3k0%no data
0.43%
UBS Asset Management AG
128,800US$328.4k-0.38%no data